China Resources Boya Bio-pharmaceutical Group , Ltd. Goodwill

As of the most recent data (June 2026), 300294.SZ shows a goodwill of $620M. That compares with $730M in the prior-year period — down 15.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 300294.SZ's goodwill is now $620M (was $730M) — a 15.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether China Resources Boya Bio-pharmaceutical Group , Ltd. is outperforming or lagging.

Tracking 300294.SZ's goodwill over time shows whether China Resources Boya Bio-pharmaceutical Group , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $620M That compares with $730M in the prior-year period — down 15.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has China Resources Boya Bio-pharmaceutical Group , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $620M) with ownership activity and broader fundamentals.

China Resources Boya Bio-pharmaceutical Group , Ltd.'s goodwill is $620M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.